Kebee Pharmacemie Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 40 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.50 M
- Revenue Growth -9.90%
- Profit Growth -121.06%
- Ebitda 952.49%
- Net Worth -0.43%
- Total Assets 1.89%
About Kebee Pharmacemie
Kebee Pharmacemie Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 1984 and has a history of 40 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹8.50 M.
Lisika Bajaj, Lipika Bajaj, and Anand Nanivadekar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1984PTC032345
- Company No.
032345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kebee Pharmacemie?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lisika Bajaj  | Director | 18-Jan-2002 | Current |
| Lipika Bajaj | Director | 01-Apr-2013 | Current |
| Anand Nanivadekar | Director | 18-May-2016 | Current |
Financial Performance of Kebee Pharmacemie.
Kebee Pharmacemie Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.9% decrease. The company also saw a substantial fall in profitability, with a 121.06% decrease in profit. The company's net worth dipped by a decrease of 0.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kebee Pharmacemie?
Unlock access to Kebee Pharmacemie's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Amazing Adhesives Private LimitedLisika Bajaj and Anand Nanivadekar are mutual person
Charges (Loans)
₹8.50 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 1995 | State Bank Of India | ₹8.50 M | Open |
How Many Employees Work at Kebee Pharmacemie?
Unlock and access historical data on people associated with Kebee Pharmacemie, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kebee Pharmacemie, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kebee Pharmacemie's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
